DePuy Synthes: Business Overview, Financials & Competitive Analysis
DePuy Synthes scores 7/10 on the AskCyborg Cyborg Score (Strong). Established orthopedic leader with $9B+ valuation facing strategic transition; divestiture creates independence opportunity but execution risk remains. DePuy Synthes operates as a diversified orthopedic medical device leader with strong global market presence, established product portfolios across trauma, joint reconstruction, and spine. However, ongoing litigation liabilities and the announced J&J spinoff.
What is DePuy Synthes's industry? DePuy Synthes (depuysynthes.com) operates in Orthopedic Devices. AskCyborg classifies DePuy Synthes under Orthopedic Devices in its company registry.
DePuy Synthes, a subsidiary of Johnson & Johnson, is a medical device company that provides products for orthopedic procedures in the areas of trauma, joint reconstruction, spine, sports medicine, cranio-maxillofacial...
Cyborg Score thesis
Established orthopedic leader with $9B+ valuation facing strategic transition; divestiture creates independence opportunity but...
Read the full analyst-debate transcript →Get the Latest DePuy Synthes Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeDePuy Synthes Overview
Pro stress-test →DePuy Synthes, a subsidiary of Johnson & Johnson, is a medical device company that provides products for orthopedic procedures in the areas of trauma, joint reconstruction, spine, sports medicine, cranio-maxillofacial, power tools and biomaterials. Johnson & Johnson announced the planned divestiture of DePuy Synthes over the following 18–24 months in October 2025, marking a strategic shift toward creating an independent orthopedic powerhouse.
Strategic Profile
Pro stress-test →DePuy develops and markets products under the Codman, DePuy Mitek, DePuy Orthopaedics and DePuy Spine brands. The company operates as a comprehensive orthopedic and neurosurgery platform serving physicians, hospitals, surgeons, and healthcare systems across domestic and international markets. The business is valued at more than $9 billion, positioning it as a significant player in global orthopedic surgery and spine solutions.
Competitive Landscape
Pro stress-test →Top competitors include Globus Medical, Bioventus and ExacTech. DePuy Synthes competes in the consolidated orthopedic medical device market against both diversified healthcare conglomerates and specialized orthopedic-focused manufacturers, with differentiation through breadth of product portfolio and global distribution infrastructure.
Industry Context
DePuy Synthes operates in Orthopedic Devices.
Key facts
Founded: 1960 · Headquarters: Warsaw, Indiana, US · Employees: 20,000 · Revenue: Unknown (J&J consolidated reporting) · Market cap: $9B+ (pending spinoff valuation)